Russell Barton
Chief Operating Officer at ACUMEN PHARMACEUTICALS, INC.
Net worth: 284 789 $ as of 31/05/2024
Profile
Mr. Russell Barton is a Director-Clinical Operations at AgeneBio, Inc., a Chief Operating Officer at Acumen Pharmaceuticals, Inc. and a President & Consultant at Pharma Sagacity Consulting LLC.
Mr. Barton was previously employed as a Chief Operating Officer by Eli Lilly & Co. He received his undergraduate degree from Illinois State University and a graduate degree from Purdue University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/01/2024 | 96,867 ( 0.16% ) | 284 789 $ | 31/05/2024 |
Russell Barton active positions
| Companies | Position | Start |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Chief Operating Officer | 01/04/2019 |
AgeneBio, Inc.
 AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Chief Tech/Sci/R&D Officer | 01/10/2019 |
| Pharma Sagacity Consulting LLC | President | 01/01/2018 |
Former positions of Russell Barton
| Companies | Position | End |
|---|---|---|
| ELI LILLY AND COMPANY | Chief Operating Officer | - |
Training of Russell Barton
| Illinois State University | Undergraduate Degree |
| Purdue University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
| Pharma Sagacity Consulting LLC |
- Stock Market
- Insiders
- Russell Barton
